Tag: Marengo Therapeutics

Marengo Presents Monotherapy Activity of Invikafusp Alfa, a First-in-Class Selective Dual T Cell Agonist in PD-1 Resistant GI Tumors, as a Late-Breaking Oral Presentation...

Promising monotherapy activity observed in all three major metastatic colorectal cancer subtypes harboring high tumor mutational burden (MSS RASwt, MSS RASmut and PD-1 resistant MSI-H)...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsMarengo Therapeutics

AI Speeds Up Returns in Private Equity as M&A Becomes Top Value Generator for Firms

True Ground Housing Partners Names the Amazon Housing Fund as 2026 Affordable Housing Honoree at Celebrate Home!

Best Stylish Prescription Glasses for Work and Everyday Wear in 2026: Quay Named a Top Pick for Fashion-Forward RX Frames by Better Business Advice

Tag: Marengo Therapeutics

Marengo Presents Monotherapy Activity of Invikafusp Alfa, a First-in-Class Selective Dual T Cell Agonist in PD-1 Resistant GI Tumors, as a Late-Breaking Oral Presentation...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us